Tetralogy of Fallot Clinical Trial
Official title:
Multicenter Post-Approval Study of Congenital Pulmonic Valve Dysfunction Studying the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System With Alterra Adaptive Prestent
| NCT number | NCT05378386 |
| Other study ID # | 2021-11 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 12, 2022 |
| Est. completion date | December 2034 |
This study will monitor device performance and outcomes in subjects undergoing implantation of the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent in the post-approval setting
| Status | Recruiting |
| Enrollment | 150 |
| Est. completion date | December 2034 |
| Est. primary completion date | December 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: 1. Native or surgically-repaired RVOT with severe PR 2. Clinically indicated for pulmonary valve replacement 3. Planned for treatment with the Alterra prestent and SAPIEN 3 THV Exclusion Criteria: 1. Inability to tolerate an anticoagulation/antiplatelet regimen 2. Active bacterial endocarditis or other active infections |
| Country | Name | City | State |
|---|---|---|---|
| Israel | Schneider Children's Medical Center of Israel | Petah Tikva | |
| United States | Colorado Children's Hospital | Aurora | Colorado |
| United States | Children's of Alabama | Birmingham | Alabama |
| United States | Boston Children's Hospital | Boston | Massachusetts |
| United States | University of Virginia | Charlottesville | Virginia |
| United States | Cincinnati Children's Hospital | Cincinnati | Ohio |
| United States | Nationwide Children's Hospital | Columbus | Ohio |
| United States | Medical City Dallas | Dallas | Texas |
| United States | Duke University | Durham | North Carolina |
| United States | Texas Children's Hospital | Houston | Texas |
| United States | Arkansas Children's Hospital | Little Rock | Arkansas |
| United States | Cedars Sinai Medical Center | Los Angeles | California |
| United States | Columbia University | New York | New York |
| United States | Icahn School of Medicine at Mount Sinai | New York | New York |
| United States | Advocate Children's Hospital | Oak Lawn | Illinois |
| United States | UPMC Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania |
| United States | Mayo Clinic | Rochester | Minnesota |
| United States | Washington University in St. Louis | Saint Louis | Missouri |
| United States | Primary Children's Hospital | Salt Lake City | Utah |
| United States | Rady's Children's Hospital | San Diego | California |
| United States | Seattle Children's Hospital | Seattle | Washington |
| United States | Stanford University | Stanford | California |
| Lead Sponsor | Collaborator |
|---|---|
| Edwards Lifesciences |
United States, Israel,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Acute Device Success | Acute Device Success, defined as a non-hierarchical composite of: Single Alterra deployed in the desired location Single THV implanted in the desired location within Alterra Right ventricle-pulmonary artery peak-to-peak gradient < 35 mmHg post-THV implantation Less than moderate total pulmonary regurgitation (PR) by discharge transthoracic echocardiogram Free of Alterra/SAPIEN 3 explant at 24 hours post-implantation |
24 hours post-procedure |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02534792 -
Early Revalvulation After Fallot Repair Improves Clinical Outcome
|
N/A | |
| Completed |
NCT00536432 -
Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot
|
N/A | |
| Not yet recruiting |
NCT05485545 -
Asynchrony in Operated Tetralogy of Fallot
|
N/A | |
| Completed |
NCT01941576 -
Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot
|
N/A | |
| Active, not recruiting |
NCT03983512 -
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
|
N/A | |
| Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
| Completed |
NCT01762124 -
Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)
|
N/A | |
| Active, not recruiting |
NCT02161471 -
Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance
|
||
| Not yet recruiting |
NCT05916976 -
Repaired Tetralogy of Fallot: Risc Score From MRI & Clinical Data to Predict the Need for Change of Treatment
|
N/A | |
| Recruiting |
NCT04106479 -
NIRS in Congenital Heart Defects - Correlation With Echocardiography
|
||
| Completed |
NCT05579964 -
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05236153 -
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
|
N/A | |
| Recruiting |
NCT03049995 -
Stress Echo 2020 - The International Stress Echo Study
|
||
| Completed |
NCT02586740 -
Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation
|
N/A | |
| Terminated |
NCT00564993 -
Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
|
Phase 3 | |
| Recruiting |
NCT05122962 -
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
|
||
| Completed |
NCT06097377 -
Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study
|
||
| Completed |
NCT03835494 -
Analysis of RV-Dysfunction in Fallot Patients
|
N/A | |
| Not yet recruiting |
NCT03275844 -
Physical Capacity and Activity in Children With Congenital Heart Disease
|
N/A | |
| Recruiting |
NCT02590679 -
Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p
|
Phase 2/Phase 3 |